|Improving Scientific Reproducibility In The Life Sciences: Considerations for Researchers, Publishers and Life Science Tool Providers|
Date: July 23, 2014 Time: 1:00 PM Eastern (10:00 AM Pacific) Duration: 60-minutes
In recent years scientific reproducibility has been a topic of much debate. This debate has been sparked in part by the now infamous “Amgen Study” conducted by Glenn Begley and team that found fewer than 7 of 53 landmark pre-clinical studies published between 2002 and 2012 could be reproduced as described in the initial publication.
The factors that contribute to poor reproducibility in pre-clinical research are complex; some relate to systemic problems in how research is conducted and funded while others relate to how research is documented and published. Recently the role that scientific suppliers, publishers and researchers can play in improving research reproducibility has come into sharp focus. Improving reagent traceability and documentation in literature have been identified as areas that can make a significant contribution.
This webinar will bring together thought leaders that are behind some of these efforts; the talks will focus on
- Reproducibility in Cancer Biology: The role of individual researchers and research institutes
- How improving research resource identification in scholarly literature can improve experimental reproducibility
- Using the scholarly record to validate research products
- Best practices in antibody validation: Insights from a Life Science manufacturer